Filing Details
- Accession Number:
- 0001708138-20-000088
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-15 16:51:52
- Reporting Period:
- 2020-07-13
- Accepted Time:
- 2020-07-15 16:51:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1796226 | J Andrew Murphy | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Research | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-07-14 | 264 | $630.77 | 44,067 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-14 | 578 | $631.32 | 43,489 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-14 | 679 | $632.12 | 42,810 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-14 | 95 | $633.02 | 42,715 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-14 | 89 | $634.18 | 42,626 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-14 | 175 | $635.46 | 42,451 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-14 | 182 | $637.48 | 42,269 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-14 | 239 | $638.96 | 42,030 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-14 | 79 | $639.55 | 41,951 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-07-13 | 13,000 | $0.00 | 13,000 | $30.63 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
13,736 | 2020-12-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 4,242 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 578 shares of Company stock on July 14, 2020 at prices ranging from $631.07 to $631.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price.
- Represents volume-weighted average price of sales of 679 shares of Company stock on July 14, 2020 at prices ranging from $632.04 to $632.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price.
- Represents volume-weighted average price of sales of 175 shares of Company stock on July 14, 2020 at prices ranging from $635.29 to $635.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price.
- Represents volume-weighted average price of sales of 182 shares of Company stock on July 14, 2020 at prices ranging from $637.19 to $637.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price.
- Represents volume-weighted average price of sales of 239 shares of Company stock on July 14, 2020 at prices ranging from $638.87 to $638.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 14, 2020 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.
- Form two of two